The Efficacy and Safety of Low Frequency Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression: The Results From a Large Multicenter French RCT

CONTEXT The aim of this study was to assess whether the combination of low frequency repetitive transcranial magnetic stimulation (rTMS) and venlafaxine (150-225 mg/day) is effective and safe for treatment-resistant unipolar depression (TRD). METHOD In a multicenter (18 centers) randomized double blind controlled trial with three arms, 170 patients were allocated to receive active rTMS combined with active venlafaxine (n = 55), active rTMS combined with placebo venlafaxine (n = 60) or sham rTMS combined with active venlafaxine (n = 55). The patients received once daily sessions of active or sham 1 Hz rTMS applied over the right dorsolateral prefrontal cortex (360 pulses/day delivered at 120% of the resting motor threshold) for two to six weeks; rTMS was combined with active or sham venlafaxine (mean dose: 179.0 ± 36.6 mg/day). The primary outcome was the number of patients who achieved remission, which was defined as an HDRS17 score <8. RESULTS We reported a similar significant antidepressant effect in the 3 groups (P < 10(-6)), with a comparable delay of action and a comparable number of remitters at the endpoint (28% in the combination group, 41% in the rTMS group and 43% in the venlafaxine group; P = 0.59). CONCLUSION Low frequency rTMS appears to be as effective as venlafaxine and as effective as the combination of both treatments for TRD. Because of its short session duration (the duration of one session was 8.5 min) and its safety, slow rTMS might be a useful alternative treatment for patients with TRD.

[1]  A. Costantini,et al.  Motor threshold in transcranial magnetic stimulation: comparison of three estimation methods , 2006, Neurophysiologie Clinique/Clinical Neurophysiology.

[2]  William W. McDonald,et al.  Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial , 2007, Biological Psychiatry.

[3]  E. Smeraldi,et al.  A Symptom-Specific Analysis of the Effect of High-Frequency Left or Low-Frequency Right Transcranial Magnetic Stimulation over the Dorsolateral Prefrontal Cortex in Major Depression , 2010, Neuropsychobiology.

[4]  G. Sayar,et al.  Hypomanic shift observed during rTMS treatment of patients with unipolar depressive disorder: four case reports , 2013, Annals of General Psychiatry.

[5]  M Feinsod,et al.  Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. , 1999, Archives of general psychiatry.

[6]  Maurizio Fava,et al.  Diagnosis and definition of treatment-resistant depression , 2003, Biological Psychiatry.

[7]  Z. Daskalakis,et al.  Clinically Meaningful Efficacy and Acceptability of Low-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Primary Major Depression: A Meta-Analysis of Randomized, Double-Blind and Sham-Controlled Trials , 2013, Neuropsychopharmacology.

[8]  J. Daléry,et al.  Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment , 2004, European Psychiatry.

[9]  William W. McDonald,et al.  Prefrontal rTMS for treating depression: Location and intensity results from the OPT-TMS multi-site clinical trial , 2013, Brain Stimulation.

[10]  P. Xie,et al.  Left versus right repetitive transcranial magnetic stimulation in treating major depression: A meta-analysis of randomised controlled trials , 2013, Psychiatry Research.

[11]  S. Patten,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. , 2009, Journal of affective disorders.

[12]  D. Schutter.  Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder , 2010, Psychological Medicine.

[13]  Sergio P. Rigonatti,et al.  Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: A double-blind placebo-controlled study , 2005, Biological Psychiatry.

[14]  S. Patten,et al.  Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. , 2009, Journal of affective disorders.

[15]  William M. Stern,et al.  Antidepressant effects of high and low frequency repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex: a double-blind, randomized, placebo-controlled trial. , 2007, The Journal of neuropsychiatry and clinical neurosciences.

[16]  P. Bech,et al.  Repetitive Transcranial Magnetic Stimulation (rTMS) in Combination with Escitalopram in Patients with Treatment-Resistant Major Depression. A Double-Blind, Randomised, Sham-Controlled Trial , 2008, Pharmacopsychiatry.

[17]  L. Garcia-Larrea,et al.  Recommandations françaises sur l’utilisation de la stimulation magnétique transcrânienne répétitive (rTMS) : règles de sécurité et indications thérapeutiques , 2011, Neurophysiologie Clinique/Clinical Neurophysiology.

[18]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[19]  J. Brunelin,et al.  Low- vs High-Frequency Repetitive Transcranial Magnetic Stimulation as an Add-On Treatment for Refractory Depression , 2012, Front. Psychiatry.

[20]  P. Fitzgerald,et al.  A randomized trial of the anti‐depressant effects of low‐ and high‐frequency transcranial magnetic stimulation in treatment‐resistant depression , 2009, Depression and anxiety.

[21]  M. Biggs,et al.  Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). , 2006, Archives of general psychiatry.

[22]  Christoph Laske,et al.  Antidepressant effects of augmentative transcranial magnetic stimulation , 2007, British Journal of Psychiatry.

[23]  E. Smeraldi,et al.  Does rTMS hasten the response to escitalopram, sertraline, or venlafaxine in patients with major depressive disorder? A double-blind, randomized, sham-controlled trial. , 2005, The Journal of clinical psychiatry.

[24]  A. Conca,et al.  Transcranial magnetic stimulation: a novel antidepressive strategy? , 1996, Neuropsychobiology.

[25]  A. Schene,et al.  Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. , 2006, The Journal of clinical psychiatry.

[26]  Á. Pascual-Leone,et al.  Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression , 2001, Journal of neurology, neurosurgery, and psychiatry.

[27]  Sarah H Lisanby,et al.  Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. , 2010, Archives of general psychiatry.

[28]  G. Freedman,et al.  Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010 , 2013, PLoS medicine.

[29]  U. Ziemann,et al.  Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline , 2002, Neuroscience Letters.

[30]  Li-xin Han,et al.  The Effects of Venlafaxine on Cortical Motor Area Activity in Healthy Subjects: A Pilot Study , 2014, Journal of clinical psychopharmacology.

[31]  P. Fitzgerald,et al.  Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. , 2003, Archives of general psychiatry.

[32]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[33]  Robert S. Pinals,et al.  A double‐blind, placebo‐controlled trial , 1986 .

[34]  J. Fermanian,et al.  A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): Therapeutic and cognitive effect in medication free unipolar depression during 4 weeks , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[35]  K. Kedzior,et al.  More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997–2013 , 2014, Neuropsychiatric disease and treatment.

[36]  Keith S. Garcia,et al.  Low frequency rTMS stimulation of the right frontal cortex is as effective as high frequency rTMS stimulation of the left frontal cortex for antidepressant-free, treatment-resistant depressed patients. , 2005, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[37]  Maurizio Fava,et al.  Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. , 2006, The New England journal of medicine.

[38]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[39]  P. Mitchell,et al.  A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. , 2008, The international journal of neuropsychopharmacology.

[40]  S. S. Ayache,et al.  Comparison of “standard” and “navigated” procedures of TMS coil positioning over motor, premotor and prefrontal targets in patients with chronic pain and depression , 2010, Neurophysiologie Clinique/Clinical Neurophysiology.

[41]  A. Gershon,et al.  Transcranial magnetic stimulation in the treatment of depression. , 2003, The American journal of psychiatry.

[42]  E. Poulet,et al.  Efficacité de la stimulation magnétique transcrânienne (rTMS) dans le traitement de la dépression : revue de la littérature , 2007 .

[43]  S. Pallanti,et al.  Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? , 2010, Neuroscience.

[44]  R. Post,et al.  Antidepressant Efficacy of High and Low Frequency rTMS at 110% of Motor Threshold versus Sham Stimulation over Left Prefrontal Cortex , 2014, Brain Stimulation.

[45]  F. Fregni,et al.  The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. , 2013, JAMA psychiatry.

[46]  Jörg Richter,et al.  Antidepressant efficacy of two different rTMS procedures , 2003, European Archives of Psychiatry and Clinical Neuroscience.

[47]  M. Bareš,et al.  Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study. , 2009, Journal of affective disorders.

[48]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .